Chaos at the CDC and the sharp move away from mRNA vaccines has public health experts alarmed.
Articles on SARS-CoV-2 virus
Displaying all articles
Two new high-profile studies add to the increasingly worrisome picture of how even mild cases of COVID-19 can have detrimental effects on brain health.
Researchers still don’t know how well BA.2.86 will evade immunity or whether it will cause more severe disease than its predecessors.
Rapid tests can be an incredibly useful tool for early detection of COVID-19. Unfortunately, they sometimes leave people with more questions than answers.
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
Top contributors
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Assistant Professor of Medicine, UMass Chan Medical School
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Associate Director of Global Health Research and Innovation Professor of Medicine, Johns Hopkins University
-
Clinical Epidemiologist, Washington University in St. Louis
-
Professor of Microbiology, School of Medicine, University of Washington